We recently attempted to amplify the CRYBB2 gene in genomic DNA samples of congenital cataract patients using the primer sets specific for exon 5 of the CRYBB2 gene (sense primer: 5 0 -CCCCTCACCCATACTCACTT-3 0 and antisense primer: 5 0 -CCCCAGAGTCTCAGTTCCTG-3 0 ) as adopted from the article by Weisschuh et al. 1 We observed an interesting result indicating three variations (rs2330991; rs2330992; rs4049504) in our sample. Upon searching for similar reports in other ethnicities, we came across an article by Hansen et al., 2 wherein the authors have reported that these variations in cis position are pathogenic, possibly by transforming the secondary structure of the beta crystallin protein, in rare circumstances, due to gene conversion. Further screening of cataract probands from three other families (SEC12, VEC2, DKEC1) using the same primer set also depicted all three variations in them. Such a possibility could either mean a sequential artifact or nonspecificity of the primers.
To clarify further, an in silico PCR using the USC Genome Browser (http://genome.ucsc.edu/cgi-bin/hgPcr; provided by the University of California at Santa Cruz) was done with the above primers, 1 which amplified two regions of the CRYBB2 and CRYBB2-P1 (NR_033,734.1) genes. CRYBB2-P1 is a pseudogene, positioned below the normal CRYBB2. Sequence comparison of CRYBB2 versus its pseudogene (CRYBB2-P1) detected all three variations referred to above in its pseudogene. To confirm, the same samples were amplified using primers cited in one of our earlier reports 3 (sense primer: 5-AGTGGTCATAGACACGTAGTGGGTGCAC-3 and antisense primer: 5-CTGTTCCCAAACTTAGGGACACACGC-3). Interestingly, the results did not show any of the three variations. This probably confirms that the said variations are due to mispriming and amplification of the pseudogene. When the primers used by Hansen et al. 2 were cross checked with the National Center for Biotechnology Information (NCBI) database, it was apparent that it matches both CRYBB2 and CRYBB2-P1. The same concordant result was obtained by in silico PCR analysis using the UCSC Genome browser. Theoretically, this primer set fails to exclusively amplify the specific CRYBB2 sequence and, hence, their data depicting the three variations in the family (CC00133) studied are rather unconvincing in accepting them as a pathogenic mutation underlying the phenotype. It is presumed that primers referred to by Hansen et al. 2 to amplify exon 5 actually denote exon 6. Further, we tested all the primers used by the authors through in silico PCR analysis using the UCSC Genome browser. It was observed that some of the primers were not specific to the genes that were screened (primers for CRYAB Exon 1 actually amplifies CRYBB1, primers for the exons CRYBB1 amplified CRYBA1 with the exception of exon 6 that amplified CRYBB1, and the reverse primer of exon 2 of MAF doesn't match with its gene sequence and, hence, showed no amplification in in silico PCR analysis).
Therefore, this situation exemplifies the importance that nonspecific amplification of a pseudogene needs to be addressed and scrutinized. With due appreciation of the interesting data presented by the authors, we wish to drive this point to the kind attention of the authors to enable rectification of the same as erratum. 
